I

InCarda Therapeutics

30 employees

Incarda Therapeutics offers a novel approach to treat cardiovascular conditions and diseases by the inhalation route.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Inhalation therapy
Cardiovascular
Pre-Clinical Research
Clinical Development
Health Diagnostics
Health Care
Drug Formulation
Regulatory Affairs
Clinical Research
Therapeutics
Commercialization
Pharmaceuticals

Date founded

2009

Funding rounds raised

Total raised

$42M

from 9 investors over 9 rounds

I

InCarda Therapeutics raised $30M on October 21, 2020

Investors: HealthCap, Morningside Venture Capital 晨兴资本 and Innoviva

I

InCarda Therapeutics raised $42M on November 8, 2018

Investors: HealthCap, Asset Management Ventures and Sofinnova Partners

I

InCarda Therapeutics raised undisclosed on January 1, 2017

Investors: Sofinnova Ventures, Russia technology fund

I

InCarda Therapeutics raised undisclosed on July 12, 2016

Investors: Asset Management Ventures

I

InCarda Therapeutics raised $5M on April 28, 2015

Investors: Morningside Private Investors

FAQ